Chicken Capsules Good For Aching Joints
Posted on: Tuesday, 1 December 2009, 12:10 CST
Chicken collagen can provide relief from rheumatoid arthritis (RA) symptoms. A randomized, controlled trial, published in BioMed Central's open access journal Arthritis Research & Therapy, has found that Chicken type II collagen (CCII), a protein extracted from the cartilage of chicken breast, is a safe and effective treatment for RA.
Wei Wei, from Anhui Medical University, China, worked with a team of researchers to test the novel treatment by comparing it to the established antirheumatic drug methotrextate, in 503 RA patients. Patients who received a 12-week course of CCII capsules showed significantly improved joint function, with fewer and milder adverse effects than those taking methotrexate. According to Wei, "We've shown that CCII is a promising alternative therapeutic strategy that may be used as a nutritional supplement against rheumatoid arthritis".
RA is an autoimmune disease caused by the body mounting a response against its own cartilage – the rubbery tissue, composed mainly of collagen, which cushions and lubricates joints. By dosing patients with collagen in the form of CCII capsules, the researchers believe that 'oral tolerance' can be developed. Wei said "Oral tolerance is a reduction in autoimmune activity caused by repeated dietary exposure to the offending substance. Treatment of autoimmune diseases by induction of oral tolerance is attractive because of the few side effects and easy clinical implementation of this approach. Indeed, our work confirms that treatment with oral CCII leads to improvement in arthritis with no significant side effects".
---
On the Net:
Related Articles
- ChemoCentryx Initiates Clinical Trial of CCX168, A Novel Small Molecule C5aR Antagonist for the Treatment of Inflammatory and Autoimmune Diseases
- Local Neurosurgeon Co-Authors National Treatment Guidelines for Brain Tumor Patients
- Sucampo Pharmaceuticals Initiates Phase 2 Trial of Cobiprostone for the Treatment of Portal Hypertension in Patients With Liver Cirrhosis
- Possible Oral Treatment for Diabetics
- Micromet and Nycomed Enter Into Exclusive Worldwide Collaboration to Develop and Commercialize Anti-GM-CSF Antibodies for the Treatment of Inflammatory and Autoimmune Diseases
- New Non-Invasive Treatment Option for Lung Cancer Patients Offered By CyberKnife Center of Miami
- Somaxon Pharmaceuticals to Announce Results of Phase 3 Clinical Trial of SILENOR(TM) for the Treatment of Insomnia in Elderly Patients and Host Conference Call
- MultiCell Establishes Clinical Development Team to Lead UK Phase IIb Human Clinical Trials for MCT-125 for the Treatment of Fatigue in MS Patients
- Advitech Completes Recruitment for Its Second Clinical Study on Oral Treatment for Psoriasis
- Clinical Data on Combination Oral Treatment Regimen Thalidomide, Melphalan and Prednisone in Newly Diagnosed Multiple Myeloma Patients
User Comments (0)
RSS Feeds